Inmedic Group ApS: Financial statements 2025
CVR: 40711171
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Inmedic Group ApS (CVR 40711171) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 102,384 and a net result of DKK 563,568 compared with DKK 441,754 the year before. That is a decrease of 3.1% compared with the year before. Equity in the 2025 report amounted to DKK 2,131,008. The solvency ratio was 99.4%.
- Gross Profit
- DKK 102,384
- Profit/Loss
- DKK 563,568
- Equity
- DKK 2,131,008
- Total Assets
- DKK 2,144,733
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 102 t. | 564 t. | 2.1 mio. | 0 |
| 2024 | - | 106 t. | 442 t. | 1.6 mio. | 0 |
| 2023 | - | 562 t. | 364 t. | 1.1 mio. | 0 |
| 2022 | - | 514 t. | 433 t. | 762 t. | 0 |
| 2021 | - | -156 t. | -166 t. | 328 t. | 0 |
Official annual report
How creditworthy is Inmedic Group ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Inmedic Group ApS has published its annual report for 2024. Gross profit came to DKK 105,637, and the net result was DKK 441,754.
About Inmedic Group ApS
Inmedic Group ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named Nordic Cannabis Research ApS. The management consists of Henrik Lund Uth. The company is owned by DAM-ANDERSEN ApS, HEMAR ApS and Schejbel Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 102,384 and a net result of DKK 563,568 compared with DKK 441,754 the year before. Equity in the 2025 report amounted to DKK 2,131,008.